BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36806702)

  • 1. Modulation of AMPK/ TET2/ 5-hmC axis in response to metabolic alterations as a novel pathway for obesity-related colorectal cancer development.
    Kon T; Sasaki Y; Abe Y; Onozato Y; Yagi M; Mizumoto N; Sakai T; Umehara M; Ito M; Nakamura S; Goto H; Ueno Y
    Sci Rep; 2023 Feb; 13(1):2858. PubMed ID: 36806702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of AMP-activated protein kinase/ten-eleven translocation 2 and their clinical relevance in colorectal cancer.
    Kang DH; Jeong DJ; Ahn TS; Lee HY; Kim HJ; Bae SB; Kim HJ; Lee MS; Kwon HY; Baek MJ
    Oncol Lett; 2021 Feb; 21(2):164. PubMed ID: 33552282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TET Family Gene Expression and 5-Hydroxymethylcytosine as Potential Epigenetic Markers in Non-small Cell Lung Cancer.
    Alrehaili AA; Gharib AF; Alghamdi SA; Alhazmi A; Al-Shehri SS; Hagag HM; Alsaeedi FA; Alhuthali HM; Raafat N; Etewa RL; Elsawy WH
    In Vivo; 2023; 37(1):445-453. PubMed ID: 36593050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.
    Minor EA; Court BL; Young JI; Wang G
    J Biol Chem; 2013 May; 288(19):13669-74. PubMed ID: 23548903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer.
    Wu D; Hu D; Chen H; Shi G; Fetahu IS; Wu F; Rabidou K; Fang R; Tan L; Xu S; Liu H; Argueta C; Zhang L; Mao F; Yan G; Chen J; Dong Z; Lv R; Xu Y; Wang M; Ye Y; Zhang S; Duquette D; Geng S; Yin C; Lian CG; Murphy GF; Adler GK; Garg R; Lynch L; Yang P; Li Y; Lan F; Fan J; Shi Y; Shi YG
    Nature; 2018 Jul; 559(7715):637-641. PubMed ID: 30022161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter.
    Shang Y; Jiang T; Ran L; Hu W; Wu Y; Ye J; Peng Z; Chen L; Wang R
    J Biol Chem; 2022 Jul; 298(7):102095. PubMed ID: 35660018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis.
    Mahfoudhi E; Talhaoui I; Cabagnols X; Della Valle V; Secardin L; Rameau P; Bernard OA; Ishchenko AA; Abbes S; Vainchenker W; Saparbaev M; Plo I
    DNA Repair (Amst); 2016 Jul; 43():78-88. PubMed ID: 27289557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
    Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting SIRT4/TET2 Signaling Alleviates Human Keratinocyte Senescence by Reducing 5-hydroxymethylcytosine Loss.
    Yi Y; Wang Y; Wu Y; Liu Y
    Lab Invest; 2024 Feb; 104(2):100268. PubMed ID: 37898292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease.
    Zhang W; Chen Z; Yi K; Su G; Liu Y; Deng Y; Zhang Y; Cao Q; Pu Y; Luo X; Lai Y; Yang P
    Clin Immunol; 2023 May; 250():109323. PubMed ID: 37019422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of 5-Hydroxymethylcytosine by TET2 Contributes to Squamous Cell Carcinoma Tumorigenesis.
    Boudra R; Woappi Y; Wang D; Xu S; Wells M; Schmults CD; Lian CG; Ramsey MR
    J Invest Dermatol; 2022 May; 142(5):1270-1279.e2. PubMed ID: 34695415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability.
    Jia J; Shi Y; Chen L; Lai W; Yan B; Jiang Y; Xiao D; Xi S; Cao Y; Liu S; Cheng Y; Tao Y
    Theranostics; 2017; 7(16):3920-3932. PubMed ID: 29109788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of ten-eleven translocation genes in endometrial cancers.
    Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
    Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear localization of TET2 requires β-catenin activation and correlates with favourable prognosis in colorectal cancer.
    Li C; He J; Meng F; Wang F; Sun H; Zhang H; Dong L; Zhang M; Xu Q; Liang L; Li Y; Yang T; He M; Wang T; Lin J; Sun J; Huang Q; Guo L; Zhang X; Mai S; Zheng H
    Cell Death Dis; 2023 Aug; 14(8):552. PubMed ID: 37620362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of nuclear localization of TET2 in colorectal cancer.
    Huang Y; Wang G; Liang Z; Yang Y; Cui L; Liu CY
    Clin Epigenetics; 2016; 8():9. PubMed ID: 26816554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
    Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
    Kudo Y; Tateishi K; Yamamoto K; Yamamoto S; Asaoka Y; Ijichi H; Nagae G; Yoshida H; Aburatani H; Koike K
    Cancer Sci; 2012 Apr; 103(4):670-6. PubMed ID: 22320381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
    Li W; Xu L
    Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET-mediated hydroxymethylcytosine at the Pparγ locus is required for initiation of adipogenic differentiation.
    Yoo Y; Park JH; Weigel C; Liesenfeld DB; Weichenhan D; Plass C; Seo DG; Lindroth AM; Park YJ
    Int J Obes (Lond); 2017 Apr; 41(4):652-659. PubMed ID: 28100914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson's disease.
    Wu TT; Liu T; Li X; Chen YJ; Chen TJ; Zhu XY; Chen JL; Li Q; Liu Y; Feng Y; Wu YC
    Hum Mol Genet; 2020 May; 29(8):1239-1252. PubMed ID: 32037456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.